NPCE vs RIDE
Neuropace Inc (NPCE) versus RIDE (RIDE) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
RIDE (RIDE) common stock.
Latest reported NPCE revenue for 2026-06-30 was $22.8M. Net income was -$6.2M. Revenue was up 3.4% from 2026-03-31 to 2026-06-30. NPCE currently screens at market cap $312.2M.
RIDE does not have a complete income-statement cache yet.
NPCE currently screens at market cap $312.2M.
Not investment advice. Open the NPCE and RIDE stock pages for the full models.
Not investment advice.